Weakness and numbness after chemotherapy for metastatic non-seminoma testis: A new neurological complication

Authors

  • Robert C. Verdonk Department of Internal Medicine, Division of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
  • Roelien H. Enting Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
  • Mirjam Janmaat Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
  • Caroline P. Schroder Department of Internal Medicine, Division of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
  • Dirk Th. Sleijfer Department of Internal Medicine, Division of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
  • Jourik A. Gietema Department of Internal Medicine, Division of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

DOI:

https://doi.org/10.1080/02841860701877330

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2008-01-01

How to Cite

Verdonk, R. C., Enting, R. H., Janmaat, M., Schroder, C. P., Sleijfer, D. T., & Gietema, J. A. (2008). Weakness and numbness after chemotherapy for metastatic non-seminoma testis: A new neurological complication. Acta Oncologica, 47(8), 1596–1598. https://doi.org/10.1080/02841860701877330